trending Market Intelligence /marketintelligence/en/news-insights/trending/CFr-CTUU9a9UdTPIZcuifQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Nektar Therapeutics exec joins AntriaBio board

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Nektar Therapeutics exec joins AntriaBio board

AntriaBio Inc. added Gil Labrucherie to its board.

Labrucherie is senior vice president and CFO of Nektar Therapeutics.